Vardenafil for Endocrine-Associated Erectile Dysfunction: Efficacy and Applications
Reading Time: 2 minutesIntroduction Erectile dysfunction (ED) affects over 30 million American men, with prevalence escalating among those with endocrine disorders such as diabetes mellitus, hypogonadism, and thyroid imbalances. According to the American Urological Association (AUA), endocrine conditions disrupt hormonal homeostasis, impairing nitric oxide (NO) signaling and vascular integrity critical for penile erection. Phosphodiesterase type 5 (PDE5) inhibitors like vardenafil—marketed as Levitra and... Read more »



